e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Respiratory medicine meets rheumatology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation
A. Tyndall (Florence, Italy)
Source:
International Congress 2018 – Respiratory medicine meets rheumatology
Session:
Respiratory medicine meets rheumatology
Session type:
Symposium
Number:
5143
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tyndall (Florence, Italy). Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation. International Congress 2018 – Respiratory medicine meets rheumatology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)
Related content which might interest you:
Systemic sclerosis and bilateral lung transplantation: a single centre experience
Source: Eur Respir J 2010; 36: 893-900
Year: 2010
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Restrictive chronic lung function decline after haematopoietic stem cell transplantation
Source: Eur Respir J 2016; 47: 336-339
Year: 2016
Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation
Source: Eur Respir J 2013; 41: 479-483
Year: 2013
Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Pretransplant lung function tests in patients with malignant hemopathy undergoing stem cell transplantation.
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Undifferentiated connective tissue disease at risk for systemic sclerosis: is heart function already impaired?
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004
Lung transplantation for systemic sclerosis and other connective tissue diseases
Source: International Congress 2017 – Difficult indications for lung transplantation
Year: 2017
Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006
Early lung function alterations after allogeneic hematopoietic stem cell transplantation
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant
Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Year: 2018
The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2008 - Pathophysiology of acute lung injury
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept